Sandbox: Difference between revisions
No edit summary |
No edit summary |
||
Line 116: | Line 116: | ||
Dental No underlying causes | Dental No underlying causes | ||
Dermatologic No underlying causes | Dermatologic No underlying causes | ||
Drug Side | Drug Side Effecte serotonin reuptake -NSAIDs,Clopidogrel,spironolactone,sirolimus,bisphosphonates (when combined with NSAIDs),mycophenolate mofetil,spironolactone ,chemotherapy (hepatic infusion of 5 - fluorouracil ,selectivinhibitor | ||
Ear Nose Throat No underlying causes | Ear Nose Throat No underlying causes | ||
Endocrine- | Endocrine- |
Revision as of 19:17, 13 October 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: : Manpreet Kaur, MD [2]
Overview
Peptic ulcer disease results from the distruption of the normal epithelial lining of the walls of stomach and small intestine. The disrupted epithelium may sometimes be superimposed by Helicobacter pylori infection. Risk factors of peptic ulcer disease include ingestion of Non-Steroidal Inflammatory Drugs (NSAIDs), stress, .
- Helicobacter pylori-(previously called as Campylobacter pylori), gram-negative,helix-shaped, microaerophilic bacteria
[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
OR
Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
OR
[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
OR
The progression to [disease name] usually involves the [molecular pathway].
OR
The pathophysiology of [disease/malignancy] depends on the histological subtype.
Causes
- Infections:
- Bacteria:
- Helicobacter pylori (60% gastric and 50-75% duodenal ulcers ) .
- Bacteria:
- Drugs-NSAIDs including aspirin{[2].Clopidogrel,spironolactone,sirolimus,bisphosphonates (when combined with NSAIDs),mycophenolate mofetil,spironolactone ,chemotherapy (hepatic infusion of 5 - fluorouracil ,selective serotonin reuptake inhibitors .
- Hormonal or mediator-induced including secondary acid hypersecretory states -Gastrinomas, systemic mastocytosis, carcinoid syndrome, myeloproliferative disorder, antral g - cell hyperfunction.
- Post-surgical -Antral exclusion and post gastric bypass surgery.
- Tumors-cancers and lymphoma
- Cameron ulcer (gastric ulcer where a hiatus hernia passes
- True idiopathic ulcer
- Crohn’s disease of the stomach or duodenum
- Eosinophilic gastroduodenitis
- Systemic mastocytosis
- Radiation damage
- Viral infections (eg, cytomegalovirus or herpes simplex
- Colonisation of stomach with H heilmanii
- Severe systemic disease
- Peptic ulcer disease is caused by gastrinomas (Zollinger-Ellison syndrome)caused by a mutation in MEN gene present on chromosome 11q13.
Pathophysiology
Pathogenesis
- The exact pathogenesis of [disease name] is not fully understood.
OR
- It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
- [Pathogen name] is usually transmitted via the [transmission route] route to the human host.
- Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
- [Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
- The progression to [disease name] usually involves the [molecular pathway].
- The pathophysiology of [disease/malignancy] depends on the histological subtype.
Genetics
- [Disease name] is transmitted in [mode of genetic transmission] pattern.
- Genes involved in the pathogenesis of [disease name] include [gene1], [gene2], and [gene3].
- The development of [disease name] is the result of multiple genetic mutations.
Associated Conditions
Gross Pathology
- On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
Microscopic Pathology
- On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
References
- ↑ 1.0 1.1 Malfertheiner P, Chan FK, McColl KE (2009). "Peptic ulcer disease". Lancet. 374 (9699): 1449–61. doi:10.1016/S0140-6736(09)60938-7. PMID 19683340.
- ↑ Hirschowitz BI, Lanas A (2002). "Atypical and aggressive upper gastrointestinal ulceration associated with aspirin abuse". J. Clin. Gastroenterol. 34 (5): 523–8. PMID 11960062.
- ↑ Jensen RT, Niederle B, Mitry E, Ramage JK, Steinmuller T, Lewington V; et al. (2006). "Gastrinoma (duodenal and pancreatic)". Neuroendocrinology. 84 (3): 173–82. doi:10.1159/000098009. PMID 17312377.
- ↑ Lee YB, Yu J, Choi HH, Jeon BS, Kim HK, Kim SW; et al. (2017). "The association between peptic ulcer diseases and mental health problems: A population-based study: a STROBE compliant article". Medicine (Baltimore). 96 (34): e7828. doi:10.1097/MD.0000000000007828. PMC 5572011. PMID 28834889.